Our product range includes a wide range of borviz 2.5 mg injection, tacrograf 0.25mg and hodpro 50 mg.
₹ 1900 Get Latest Price
Dose/Strength | 2.5 mg |
Packaging Type | Vial |
Manufactured By | Intas |
Usage/Application | Personal |
Shelf life | 24 months |
Minimum order quantity: 1 Vial
Borviz 2.5mg injection contains bortezomib, an antineoplastic agent used to treat multiple myeloma and mantle cell lymphoma. It works by inhibiting the growth of cancer cells. Bortezomib is administered as an injection by a healthcare professional.
₹ 110 Get Latest Price
Strength | 0.25 mg |
Packaging Size | 1*10 Capsules |
Minimum order quantity: 6 Strip
Tacrograf 0.25 Capsule is an immunosuppressant. It works by suppressing your body's immune response following the transplant of an organ (e.g., liver, kidney, heart). This helps your body to accept the new organ as if it were your own.
₹ 1900 Get Latest Price
Strength | 50 mg |
Form | Tablet |
Storage Condition | Store below 25 degree protected from light and moisture |
Minimum order quantity: 5 Box
Hodpro is a brand name for a medication containing the active ingredient procarbazine, primarily used in chemotherapy. Procarbazine is an alkylating agent, meaning it works by damaging the DNA of cancer cells to prevent them from growing and dividing. It's commonly used as part of combination chemotherapy regimens, particularly for treating Hodgkin's lymphoma and certain other cancers.
Anil Damodar (Ceo)
New Delhi Speciality Pharma
LGF, 150, Karol Bagh, Delhi
Motia Khan, New Delhi - 110055, Delhi, India